DVA
DaVita Inc

2,202
Mkt Cap
$9.52B
Volume
684,479.00
52W High
$179.60
52W Low
$115.39
PE Ratio
12.52
DVA Fundamentals
Price
$122.00
Prev Close
$123.05
Open
$123.40
50D MA
$127.70
Beta
0.56
Avg. Volume
772,568.78
EPS (Annual)
$10.73
P/B
-15.09
Rev/Employee
$168,625.66
Loading...
Loading...
News
all
press releases
Boston Partners Sells 12,151 Shares of DaVita Inc. $DVA
Boston Partners decreased its holdings in shares of DaVita Inc. (NYSE:DVA - Free Report) by 13.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·4h ago
News Placeholder
More News
News Placeholder
Berkshire Builds $4.9 Billion Stake In Alphabet; Adds To Chevron; Sells More Apple And Bank of America
Berkshire Builds $4.9 Billion Stake In Alphabet; Adds To Chevron; Sells More Apple And Bank of America With less than two months left until the Berkshire Hathway becomes just another company after...
Zero Hedge·14h ago
News Placeholder
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Inc. to Participate in Fireside Chat with Wolfe Research DaVita Inc. to Participate in Fireside Chat with Wolfe Research PR Newswire DENVER, Nov. 14, 2025 DENVER, Nov. 14, 2025 /PRNewswire...
PR Newswire·16h ago
News Placeholder
Illinois Municipal Retirement Fund Purchases 4,010 Shares of DaVita Inc. $DVA
Illinois Municipal Retirement Fund boosted its position in DaVita Inc. (NYSE:DVA - Free Report) by 15.1% during the second quarter, according to its most recent disclosure with the Securities and...
MarketBeat·1d ago
News Placeholder
DaVita Inc. $DVA Holdings Lowered by Bank of Montreal Can
Bank of Montreal Can reduced its stake in DaVita Inc. (NYSE:DVA - Free Report) by 62.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·4d ago
News Placeholder
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025...
PR Newswire·11d ago
News Placeholder
DaVita Stock Down Post Q3 Earnings Miss Estimates, Revenues Up Y/Y
DVA's Q3 earnings miss estimates despite revenue growth, as margins tightened and shares slipped post-results.
Zacks·16d ago
News Placeholder
DaVita HealthCare (DVA) Q3 Earnings Lag Estimates
DaVita HealthCare (DVA) delivered earnings and revenue surprises of -23.71% and +0.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
DaVita Inc. 3rd Quarter 2025 Results
DaVita Inc. 3rd Quarter 2025 Results DaVita Inc. 3rd Quarter 2025 Results PR Newswire DENVER, Oct. 29, 2025 DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and...
PR Newswire·17d ago
News Placeholder
Can Technology and Cost Discipline Lift DaVita's Q3 Earnings?
DVA's third-quarter 2025 performance is likely to benefit from technology upgrades and cost control while battling high missed treatments and low volume growth.
Zacks·18d ago

Latest DVA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.